Guidelines of care for clinical laser treatments: why are they useful?

Ibrahim, Sarah A.; Kang, Bianca Y.; Poon, Emily; Alam, Murad

doi:10.1007/s10103-021-03473-0

Cited by 4 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Referral to consultations is given toward dermatology and oncology. Differential diagnoses are broad depending on the variant and includes other skin cancers, such as basal cell carcinoma, amelanotic melanoma, burns, infectious diseases, lichenoid diseases 5 …”

Section: Introductionmentioning

confidence: 99%

Squamous cell carcinoma: 2021 updated review of treatment

Dreyfuss

Kamath

Frech

et al. 2022

Dermatologic Therapy

View full text Add to dashboard Cite

Squamous cell carcinoma is the second most common cutaneous malignancy, requiring early diagnosis to prevent metastasis. Updated guidelines in the definition of clinical features, diagnostic modalities, grading, staging, surgical, and nonsurgical treatment methods are necessary. Diagnostic methods from biopsy, dermoscopy, and reflectance confocal microscopy have improved to include high-frequency ultrasonography, optical coherence tomography, and computed tomography. Non-surgical treatment methods include topical therapy, cryosurgery, photodynamic therapy, and radiation. Surgical treatment methods include surgical excision with margins and Mohs surgery. Clinical trials encourage further research to address the knowledge base of genetic variations and lymph node metastasis.

show abstract

Section: Introductionmentioning

confidence: 99%

Squamous cell carcinoma: 2021 updated review of treatment

Dreyfuss

Kamath

Frech

et al. 2022

Dermatologic Therapy

View full text Add to dashboard Cite

show abstract

“…In the numerous laser treatment clinical practice guidelines available, laser test spots are not consistently mentioned or recommended. [5][6][7][8][9] When mentioned, the parameters evaluated during the test spot and its objectives are seldom standardized. For example, time for reassessment can vary from minutes to days or weeks.…”

mentioning

confidence: 99%

Laser Test Spots: A Scoping Review

Chong,

Shi,

Richer

2024

Dermatol Surg

View full text Add to dashboard Cite

BACKGROUND Laser test spots are commonly suggested for the assessment of clinical response and adverse effects, but use by laser operators is not well described. OBJECTIVE To describe the use of laser test spots in the existing published literature regarding methodology (location, treatment parameters) and objective (clinical efficacy, safety, other). MATERIALS AND METHODS This scoping review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines and included indexed studies performing test spots in human subjects for dermatologic conditions with clinical reassessment at a subsequent visit. RESULTS Among 5,261 identified publications, 103 studies with 959 test spots were selected for inclusion. Test spots conducted were mostly on lesional skin (89.3%) assessing both clinical response and adverse effects (76.9%). Most test spots used multiple laser parameters with a single wavelength (48.3%). Fluence was most frequently adjusted either alone (30.1%) or in combination with pulse duration or spot size. Other described test spots examined single set of laser parameters, multiple wavelengths with various parameters, or were left unspecified. CONCLUSION Laser test spot methodology was diverse and performed for dual objectives of efficacy and safety. The authors have compiled clinical considerations to assist laser operators in deciding whether performing a test spot may be beneficial to their patient.

show abstract